Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-02-18 to 2022-03-14
Current total value of award: $25607.82
Description: 4556411298!TYSABRI 300 MG/15 ML VIAL 15ML